| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 2,5 M € | +6.0% | 2,3 M € | +2291.7% | 98,0 k € | -3.5% | 101,6 k € | -10.8% | 113,9 k € | +32.1% | 86,3 k € | -37.3% | 137,6 k € | -6.4% | 147,0 k € | -6.9% | 157,8 k € | -3.8% | 164,0 k € | +0.5% | 163,2 k € | +4.6% | 156,0 k € | -13.2% | 179,7 k € | +12.0% | 160,5 k € | +14.0% | 140,8 k € | -15.2% | 166,1 k € | +136.4% | 70,3 k € | +28.6% | 54,6 k € | +5.5% | 51,8 k € | |
| EBITDA | 1,4 M € | +1.0% | 1,4 M € | +1390.2% | 93,9 k € | -6.7% | 100,6 k € | -9.4% | 111,1 k € | +33.5% | 83,2 k € | -12.8% | 95,4 k € | -33.3% | 143,1 k € | -6.4% | 152,9 k € | -4.9% | 160,8 k € | +0.6% | 160,0 k € | +5.8% | 151,2 k € | -13.6% | 175,1 k € | +11.2% | 157,4 k € | +21.6% | 129,4 k € | -16.7% | 155,4 k € | +157.4% | 60,4 k € | +33.4% | 45,2 k € | +6.2% | 42,6 k € | |
| Operating profit | 922,4 k € | +2.1% | 903,2 k € | +1133.6% | 73,2 k € | -9.4% | 80,8 k € | -11.9% | 91,7 k € | +54.4% | 59,4 k € | -17.1% | 71,6 k € | -27.2% | 98,4 k € | -14.8% | 115,5 k € | -7.3% | 124,6 k € | -0.3% | 125,0 k € | +11.1% | 112,5 k € | -18.5% | 138,1 k € | +13.2% | 122,0 k € | +33.6% | 91,3 k € | -24.1% | 120,3 k € | +185.7% | 42,1 k € | +56.1% | 27,0 k € | +9.4% | 24,7 k € | |
| Profit/loss | 550,6 k € | -74.4% | 2,1 M € | +4828.4% | 43,6 k € | +26.4% | 34,5 k € | -50.8% | 70,1 k € | +65.6% | 42,3 k € | -16.7% | 50,8 k € | -15.9% | 60,4 k € | -14.4% | 70,6 k € | -0.4% | 70,8 k € | +8.8% | 65,1 k € | +30.6% | 49,8 k € | -11.6% | 56,4 k € | +27.6% | 44,2 k € | +78.0% | 24,8 k € | -36.9% | 39,3 k € | +194.8% | 13,3 k € | +12.1% | 11,9 k € | +12.7% | 10,6 k € | |
| Equity | 3,5 M € | +18.6% | 3,0 M € | +267.0% | 804,7 k € | +5.7% | 761,1 k € | +4.7% | 726,6 k € | +10.7% | 656,5 k € | +6.9% | 614,2 k € | +9.0% | 563,3 k € | +12.0% | 502,9 k € | +16.3% | 432,3 k € | +19.6% | 361,5 k € | +22.0% | 296,4 k € | +20.2% | 246,5 k € | +29.6% | 190,2 k € | +30.3% | 146,0 k € | +20.5% | 121,2 k € | +48.0% | 81,8 k € | +19.5% | 68,5 k € | +21.0% | 56,6 k € | |
| Total assets | 6,7 M € | +2.6% | 6,5 M € | +247.5% | 1,9 M € | +0.5% | 1,9 M € | -2.7% | 1,9 M € | +1.8% | 1,9 M € | -4.8% | 2,0 M € | -3.4% | 2,1 M € | -4.2% | 2,1 M € | +4.0% | 2,1 M € | -1.3% | 2,1 M € | -2.3% | 2,1 M € | -1.2% | 2,2 M € | -2.3% | 2,2 M € | -1.7% | 2,3 M € | -0.8% | 2,3 M € | +800.1% | 252,2 k € | -12.1% | 287,0 k € | +4.1% | 275,7 k € | |
| Cash | 1,1 M € | +30.7% | 856,2 k € | +1473.2% | 54,4 k € | +89.8% | 28,7 k € | -41.3% | 48,9 k € | +205.6% | 16,0 k € | -38.2% | 25,9 k € | -29.7% | 36,9 k € | -75.3% | 149,2 k € | +665.2% | 19,5 k € | -49.4% | 38,5 k € | +26.9% | 30,4 k € | +65.2% | 18,4 k € | -7.1% | 19,8 k € | -40.4% | 33,2 k € | +26.1% | 26,4 k € | +782.0% | 3,0 k € | -92.7% | 41,1 k € | +110.3% | 19,6 k € | |
| Debts | 3,1 M € | -10.7% | 3,5 M € | +252.1% | 991,5 k € | -3.3% | 1,0 M € | -6.6% | 1,1 M € | -4.4% | 1,1 M € | -10.8% | 1,3 M € | -8.6% | 1,4 M € | -9.7% | 1,6 M € | +0.8% | 1,5 M € | -5.9% | 1,6 M € | +7.3% | 1,5 M € | -5.6% | 1,6 M € | -7.0% | 1,7 M € | -5.0% | 1,8 M € | -11.4% | 2,1 M € | +1962.6% | 100,3 k € | -36.8% | 158,7 k € | -5.0% | 167,2 k € | |
| Staff | 15,2 | 15,4 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||
Private limited company · Ranst · incorporated on 15/06/2000 · 15,2 ETP
Private limited company profitable and well capitalised. Cash position rising (+30.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
APOTHEEK VERHEIJEN is a Private limited company incorporated in 2000. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Ranst. It employs on average 15,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette